Streetbeat News

Earnings

RVYL

Ryvyl (NASDAQ:RVYL) reported Q4 earnings with an EPS of $-1.17, missing estimates by -192.0% against an expected $-0.4. Revenue increased by $11.15 million year-over-year. Historically, Ryvyl's share price dropped 9.0% the day after missing EPS estimates last quarter.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 9:00 pm

INTZ

Intrusion (NASDAQ:INTZ) reported Q4 earnings with an EPS of $-0.09, beating estimates by 18.0% but with a revenue decrease of $78 thousand from the previous year. The company's past earnings performance shows a pattern of missing EPS estimates, leading to significant share price drops.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 9:00 pm

XYF

X Financial (NYSE:XYF) reported a decrease in Q4 adjusted earnings per ADS to $0.66 from $0.76 YoY, while sales increased to $168.00M from $138.55M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:56 pm

PBLA

Panbela Therapeutics (OTC:PBLA) reported Q4 earnings with an EPS of $-65.9, missing estimates by -171.0% and showing no revenue change from the previous year. Despite past earnings misses leading to share price increases, this significant miss could impact investor sentiment.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:55 pm

STOK

Stoke Therapeutics Inc (NASDAQ:STOK) shares surged over 58% on Tuesday after announcing promising Phase 1/2a data for STK-001 in Dravet syndrome. The company also announced a proposed public offering of up to $75 million of its common stock, intending to use the proceeds for research and development of its product candidates, including STK-001 and STK-002.

Portfolio Pulse from Adam Eckert

March 26, 2024 | 8:54 pm

PBLA

Panbela Therapeutics (NASDAQ:PBLA) reported a Q4 2023 GAAP EPS loss of $(65.90), significantly missing the analyst consensus estimate of $(24.34) by 170.75%.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:51 pm

DJT

RUM

Rumble Inc. (NASDAQ:RUM) shares surged, possibly due to Trump Media & Technology Group Corp. (NASDAQ:DJT) debuting on Nasdaq. Rumble's CEO congratulated Trump Media on X and discussed Rumble's offer to buy TikTok on Fox Business. Rumble is expected to report Q4 financial results with estimated losses of 22 cents per share and revenue of $28.127 million. Rumble's stock closed up 16.10% at $57.99.

Portfolio Pulse from Erica Kollmann

March 26, 2024 | 8:47 pm

PRGS

Progress Software (NASDAQ:PRGS) reported Q1 2024 earnings of $1.25 per share, surpassing the consensus estimate of $1.14. Sales reached $184.685M, exceeding estimates of $181.909M and marking an 11.52% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:46 pm

AMAT

Recent unusual options activity in Applied Materials (NASDAQ:AMAT) shows a bullish stance by significant investors, with a mix of bullish and bearish trades. The activity suggests a price target range of $160 to $310. Notable trades include both puts and calls with varying sentiments and strike prices. Applied Materials, a leading semiconductor equipment manufacturer, has seen its stock price slightly decrease. Analysts have mixed ratings on AMAT, with target prices ranging from $220 to $240. The next earnings report is expected in 51 days.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:45 pm

BIOR

Biora Therapeutics (NASDAQ:BIOR) reported Q4 earnings with an EPS of $-0.63, missing estimates by -7%, and a revenue decrease of $14 thousand from the previous year. This follows a pattern from the last quarter where despite beating EPS estimates, the share price dropped by 2% the next day.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:45 pm